Michael Chorev
37Patents
13h-index
42Co-inventors
81Inventor score
Filing activity: May 26, 1987 → Nov 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5217999A | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | Chemistry; Metallurgy | 183 | Expired |
| US4948807A | Phenyl carbamates | Chemistry; Metallurgy | 48 | Expired |
| US5747456A | Continuous low-dose administration of parathyroid hormone or its agonist | Chemistry; Metallurgy | 40 | Expired |
| US6462222B1 | Aminoindan derivatives | Chemistry; Metallurgy | 39 | Expired |
| US4771124A | Parathyroid hormone antagonists with simplified synthetic methodology | Human Necessities | 35 | Expired |
| US4968669A | Parathyroid hormone antagonists | Human Necessities | 33 | Expired |
| US5461034A | Osteogenic growth polypeptides identified from regenerating bone marrow | Emerging Cross-Sectional Technologies | 29 | Expired |
| US5093233A | Antagonists with position 13 modification | Human Necessities | 26 | Expired |
| US5001223A | Parathyroid hormone antagonists with enhanced metabolic properties | Human Necessities | 22 | Expired |
| US5149779A | Humoral hypercalcemic factor antagonists | Chemistry; Metallurgy | 20 | Expired |
| US5717062A | Cyclic analogs of PTH and PTHrP | Human Necessities | 20 | Expired |
| US6303650A | Aminoindan derivatives | Chemistry; Metallurgy | 17 | Expired |
| US6251938A | Phenylethylamine derivatives | Chemistry; Metallurgy | 16 | Expired |
| US5087562A | Humoral hypercalcemic factor antagonists with modification at position 13 . . . | Emerging Cross-Sectional Technologies | 13 | Expired |
| US5814610A | Osteogenic growth oligopeptides and pharmaceutical compositions containing them | Human Necessities | 13 | Expired |
| US6538025B2 | Aminoindan derivatives | Chemistry; Metallurgy | 12 | Expired |
| USRE38761E1 | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | General | 9 | Expired |
| US7799757B2 | Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents | Human Necessities | 7 | Expired |
| US9421211B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | Chemistry; Metallurgy | 7 | Active |
| US6479460B1 | Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same | Human Necessities | 6 | Expired |
| US8257931B2 | Regulation of protein synthesis | Physics | 4 | Active |
| USRE39616E1 | Aminoindan derivatives | General | 4 | Expired |
| US9068006B2 | Glycated CD59 peptides, their preparation, and uses thereof | Physics | 4 | Active |
| US5242680A | Thiol-reactive maleimido-based radiolabeling reagents | Human Necessities | 4 | Expired |
| US5087561A | Humoral hypercalcemic factor antagonists modified at position 13 by biotin | Emerging Cross-Sectional Technologies | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.